guido j neels  bioventus our company guido j neels bioventus t guido j neels guido neels managing director of essex woodlands has over  years of experience developing international healthcare businesses from may  until retiring in november  neels served as chief operating officer of guidant corporation a world leader in the development of cardiovascular medical products where he was responsible for the global operations of guidant’s four operating units – cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to may  he was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations from january  to december  he was president of guidant for europe middle east africa and canada he previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations from  to  until guidant was spun off as an independent public company from eli lilly and co neels held general management sales and marketing positions at lilly in the us and europe from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the us neels joined essex woodlands as a partner in august  and was promoted to managing director in  in addition to the portfolio company boards on which he serves rox medical entellus medical oraya therapeutics clear vascular and endologix neels also serves on the board of directors for arsenal medical and endgenitor technologies neels holds his business engineering degree from the university of leuven belgium and his mba from stanford university about bioventus leadership board members anthony p bihl iii phil cowdy william a “bill” hawkins iii michael minogue guido j neels guy p nohra david parker cyrille petit marty sutter partnerships grants committee compliance guido j neels managing director essex woodlands timesjavascript is disabled market profiles login sign up login sign up   edit person guido j neels managing director at essex woodlands location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop guido j neels managing director at essex woodlands location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop guido neels has over  years of experience developing international healthcare businesses from may  until retiring in november  mr neels served as chief operating officer of guidant corporation a world leader in the development of cardiovascular medical products where he was responsible for the global operations of guidant’s four operating units – cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to may  he was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations from january  to december  he was president of guidant for europe middle east africa and canada he previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations from  to  until guidant was spun off as an independent public company from eli lilly and co mr neels held general management sales and marketing positions at lilly in the us and europe from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the us mr neels currently serves as the chairman of the board of directors for oraya therapeutics and serves on the board of directors for entellus medical endologix and bioventus in addition to the portfolio company boards on which he serves mr neels also serves on the board of directors for arsenal medical  medical which was spun out of arsenal medical endgenitor technologies and christel house international mr neels holds a business engineering degree from the university of leuven in belgium and a master of business administration degree from stanford university mr neels joined essex woodlands as a partner in august  was promoted to managing director in  and was appointed to operating partner in february   companies in career na related markets  colleagues  related investments alias na industry venture capital tags private equity venture capital pharmaceuticals topics of influence na na careers achievements investments related people edit view all guido j neelscareer   essex woodlands managing director jun oraya therapeutics board member aug to  essex woodlands partner  to  guidant chief operating officer competencies edit view all guido j neelseducation  university of leuven belgium stanford university edit guido j neelsachievements and recognitions add milestone no milestones has been recorded for guido j neels edit guido j neelslinks add link no links has been recorded for guido j neels guido j neelsinvestmentsacquisitions no investments has been recorded for guido j neels view all guido j neelsinvestments representing others lead oraya therapeutics representing essex woodlands health ventures since jun series a b c company status private guido j neelsrelated people colleagues at essex woodlands ron eastman managing director oct marty sutter managing director jim currie managing director cofounder new york view all peers  bradley bolzon managing director of versant ventures thomas woiwode managing director of versant ventures bill link managing director of versant ventures kirk nielsen managing director of versant ventures donald milder managing director of versant ventures marty sutter managing director of essex woodlands view all guido j neelsrecommended market profiles healthcare venture deals    employees  companies guido j neelshbr hdirectorhh  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses guido j neelsdirector management team karen zaderej president chief executive officer and director peter j mariani chief financial officer gregory g freitag general counsel senior vice president business development director jon gingrich chief commercial officer shawn mccarrey senior vice president of sales kevin leach vice president of marketing mark friedman phd vice president of regulatory affairs and quality assurance erick devinney vice president of clinical and translational sciences mike donovan vice president of operations david hansen vice president of finance and treasurer board of directors jamie m grooms chairman and director mark gold md director amy wendell director guido j neels director robert j rudelius director karen zaderej president chief executive officer and director gregory g freitag general counsel senior vice president business development director news  press resources all news press kit guido j neels mr neels has served as a member of the board of directors of axogen inc since august   he has been an operating partner of ew healthcare partners ew since february   mr neels joined ew as a partner in august  was promoted to managing director in  and served in that position until appointed to operating partner  from may  until retiring in november  mr neels served as chief operating officer of guidant corporation “guidant” a world leader in the development of cardiovascular medical products where he was responsible for the global operations of guidant’s four operating units  cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions  from december  to may  mr neels was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations  from january  to december  mr neels was president of guidant for europe middle east africa and canada  mr neels previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations  from  to  until guidant was spun off as an independent public company from eli lilly and co “eli lilly” mr neels held general management sales and marketing positions at eli lilly in the united states and europe  from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the united states mr neels currently serves on the board of directors for axogen inc entellus medical endologix inc and bioventus llc in addition to these ew portfolio company boards on which he serves mr neels also serves on the board of directors for arsenal medical  biomedical which was spun out of arsenal medical and christel house international a notforprofit organization mr neels holds a business engineering degree from the university of leuven in belgium and a master of business administration degree from stanford university latest news july   axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   axogen inc appoints jon gingrich chief commercial officer june   axogen inc to present at the jmp securities life sciences conference may   axogen inc to present at the jefferies global healthcare conference contact information we would love to hear from you phoneaxogen  fax autofax emailcustomercareaxogeninccom axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address guido j neelshbr hdirectorhh  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses guido j neelsdirector management team karen zaderej president chief executive officer and director peter j mariani chief financial officer gregory g freitag general counsel senior vice president business development director jon gingrich chief commercial officer shawn mccarrey senior vice president of sales kevin leach vice president of marketing mark friedman phd vice president of regulatory affairs and quality assurance erick devinney vice president of clinical and translational sciences mike donovan vice president of operations david hansen vice president of finance and treasurer board of directors jamie m grooms chairman and director mark gold md director amy wendell director guido j neels director robert j rudelius director karen zaderej president chief executive officer and director gregory g freitag general counsel senior vice president business development director news  press resources all news press kit guido j neels mr neels has served as a member of the board of directors of axogen inc since august   he has been an operating partner of ew healthcare partners ew since february   mr neels joined ew as a partner in august  was promoted to managing director in  and served in that position until appointed to operating partner  from may  until retiring in november  mr neels served as chief operating officer of guidant corporation “guidant” a world leader in the development of cardiovascular medical products where he was responsible for the global operations of guidant’s four operating units  cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions  from december  to may  mr neels was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations  from january  to december  mr neels was president of guidant for europe middle east africa and canada  mr neels previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations  from  to  until guidant was spun off as an independent public company from eli lilly and co “eli lilly” mr neels held general management sales and marketing positions at eli lilly in the united states and europe  from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the united states mr neels currently serves on the board of directors for axogen inc entellus medical endologix inc and bioventus llc in addition to these ew portfolio company boards on which he serves mr neels also serves on the board of directors for arsenal medical  biomedical which was spun out of arsenal medical and christel house international a notforprofit organization mr neels holds a business engineering degree from the university of leuven in belgium and a master of business administration degree from stanford university latest news july   axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   axogen inc appoints jon gingrich chief commercial officer june   axogen inc to present at the jmp securities life sciences conference may   axogen inc to present at the jefferies global healthcare conference contact information we would love to hear from you phoneaxogen  fax autofax emailcustomercareaxogeninccom axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address radiant medical announces guido j neels joins board of directors employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       radiant medical announces guido j neels joins board of directors tweet   pm redwood city calif may  prnewswire  radiant medical inc a private medical device company pioneering the development of endovascular therapeutic cooling for the treatment of heart brain and kidney disorders today announced that guido j neels recently retired chief operating officer of guidant corporation has been elected to the companys board of directors radiant medical is sponsoring the cool mi ii trial a safety and efficacy clinical study designed to demonstrate that lowering core body temperature before and after primary percutaneous coronary intervention in the treatment of an acute myocardial infarction heart attack will minimize damage to the heart muscle im very pleased about joining radiant medical at this stage of their development and look forward to working closely with their excellent team and prominent investors stated guido neels the companys new devicebased therapy holds enormous potential for the over two million patients worldwide who suffer heart attacks each year said neels in addition to minimizing severe damage to the heart due to oxygendeprivation clinical research has shown that endovascular therapeutic hypothermia may also result in reduced inflammation and enhance tissue healing all of this may lead to faster more complete recoveries and hopefully a better quality of life for these patients we are fortunate to have an individual of the caliber of guido neels who brings over  years of financial managerial and global experience to the company said kenneth g hayes jr president and chief executive officer of radiant medical his business expertise and his role managing guidant one of the worlds leading cardiovascular medical product companies will add tremendous value to radiant medical mr neels joins five other distinguished members of radiant medicals board of directors in addition to mr hayes the other board members are mark a wan a general partner at three arch partners jeani delagardelle a managing director at new leaf venture partners william g gerber md a partner at bay city capital and michael l eagle retired vice president of manufacturing for eli lilly and company about guido j neels guido j neels served as chief operating officer of guidant corporation a world leader in the development of cardiovascular medical products from may  until retiring in november  he was responsible for the global operations of guidants four operating units cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to may  he was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations from january  to december  he was president of europe middle east africa and canada he previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations from  until guidant was spun off as an independent public company from eli lilly and co in  mr neels held various general management and sales and marketing positions at lilly in europe and the us from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the us mr neels has been an independent director with biopure corporation since august  he holds a master of business administration degree from stanford university and a business engineering degree from the university of leuven in belgium about radiant medical inc radiant medical inc headquartered in redwood city california is a private medical device company focused on the development of stateoftheart endovascular temperature therapy systems to advance the treatment of patients with acute ischemic or inflammatory conditions such as acute myocardial infarction radiocontrast nephropathy cardiac arrest and stroke radiant medical inc contact craig straley vice president of radiant medical inc or inforadiantmedicalcom web site httpwwwradiantmedicalcom read at biospacecom related news radiant medical raises  million in private equity financingdr gerald j yakatan appointed ceo of cobalis corp clscob radiant medical announces launch of new cooling trial in heart attack patientslonnie bookbinder selected as ceo of specigen a new montana biotechnology company neopharm neol announces cost rationalization program cutting  of jobs inhibitex inc inhx announces a reduction in its workforce millenium biologix inc provides update on actestm regulatory strategy withdraws peptostm ide submission and announces resignation of cfo proteon therapeutics inc hires veteran biotechnology executive timothy noyes as ceo amir avniel named chief executive officer of rosetta genomics ltd biolase technology inc blti ceo resigns please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • radiant medical   • biotechpharma  personnel                 radiant medical announces guido j neels joins board of directors skip navigation menu radiant medical announces guido j neels joins board of directorsback to press  events radiant medical inc a private medical device company pioneering the development of endovascular therapeutic cooling for the treatment of heart brain and kidney disorders today announced that guido j neels recently retired chief operating officer of guidant corporation has been elected to the company’s board of directors mr neels joins five other distinguished members of radiant medical’s board of directorsredwood cityca may    radiant medical inc a private medical device company pioneering the development of endovascular therapeutic cooling for the treatment of heart brain and kidney disorders today announced that guido j neels recently retired chief operating officer of guidant corporation has been elected to the company’s board of directors radiant medical is sponsoring the cool mi ii trial a safety and efficacy clinical study designed to demonstrate that lowering core body temperature before and after primary percutaneous coronary intervention in the treatment of an acute myocardial infarction heart attack will minimize damage to the heart muscle“i’m very pleased about joining radiant medical at this stage of their development and look forward to working closely with their excellent team and prominent investors” stated guido neels “the company’s new devicebased therapy holds enormous potential for the over two million patients worldwide who suffer heart attacks each year” said neels “in addition to minimizing severe damage to the heart due to oxygendeprivation clinical research has shown that endovascular therapeutic hypothermia may also result in reduced inflammation and enhance tissue healing all of this may lead to faster more complete recoveries and hopefully a better quality of life for these patients”“we are fortunate to have an individual of the caliber of guido neels who brings over  years of financial managerial and global experience to the company said kenneth g hayes jr president and chief executive officer of radiant medical “his business expertise and his role managing guidant one of the world’s leading cardiovascular medical product companies will add tremendous value to radiant medical”mr neels joins five other distinguished members of radiant medical’s board of directors in addition to mr hayes the other board members are mark a wan a general partner at three arch partners jeani delagardelle a managing director at new leaf venture partners william g gerber md a partner at bay city capital and michael l eagle retired vice president of manufacturing for eli lilly and companyabout guido j neelsguido j neels served as chief operating officer of guidant corporation a world leader in the development of cardiovascular medical products from may  until retiring in november  he was responsible for the global operations of guidants four operating units cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to may  he was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations from january  to december  he was president of europe middle east africa and canada he previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations from  until guidant was spun off as an independent public company from eli lilly and co in  mr neels held various general management and sales and marketing positions at lilly in europe and the us from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the usmr neels has been an independent director with biopure corporation since august  he holds a master of business administration degree from stanford university and a business engineering degree from the university of leuven in belgiumabout radiant medical incradiant medical inc headquartered in redwood city california is a private medical device company focused on the development of stateoftheart endovascular temperature therapy systems to advance the treatment of patients with acute ischemic or inflammatory conditions such as acute myocardial infarction radiocontrast nephropathy cardiac arrest and strokecontactradiant medical inccraig straleyvice president inforadiantmedicalcom wwwradiantmedicalcom   share on ceoken hayesmore news on radiant medicalradiant medical trial shows promising results in preventing kidney damageradiant medical initiates clinical trial of therapeutic cooling for kidney protection radiant medical announces guido j neels joins board of directorshighland team corey mulloy highland capital partners common app apply now review companies connect more   highland capital partners guido j neels  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in guido j neels board member at endologix inc view full profile are you guido j neels claim your profile   sign up for equilar atlas and view guido j neelss full profile with equilar atlas you can identify corporate executives in guido j neelss network and community follow changes in guido j neelss employment and moneyinmotion connect with guido j neels through your network of contacts guido j neelss executive work history current board member endologix inc board member axogen inc past to view guido j neelss complete executive work history sign up now age      guido j neelss biography guido j neels  has served on our board of directors since december  mr neels has been a managing director at essex woodlands health ventures inc or essex woodlands a venture capital firm since  prior to joining essex woodlands mr neels served in a variety of management positions at guidant corporation a developer of cardiovascular medical products from july  until retiring in november  mr neels served as guidants chief operating officer where he was responsible for the global operations of guidants four operating units cardiac rhythm management vascular intervention cardiac surgery and endovascular so  read more guido j neels  has served on our board of directors since december  mr neels has been a managing director at essex woodlands health ventures inc or essex woodlands a venture capital firm since  prior to joining essex woodlands mr neels served in a variety of management positions at guidant corporation a developer of cardiovascular medical products from july  until retiring in november  mr neels served as guidants chief operating officer where he was responsible for the global operations of guidants four operating units cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to july  mr neels served as guidants group chairman office of the president responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations in january  mr neels was named guidants president europe middle east africa and canada in addition mr neels served as guidants vice president global marketing vascular intervention from  to  and as guidants general manager germany and central europe from  to  mr neels has a business engineering degree from the university of leuven in belgium and an mba from the stanford university graduate school of business mr neels served on the boards of directors of biopure corporation a publiclyheld medical device company from  to  lemaitre vascular inc a publiclyheld medical device company from  to  and nellix inc a privatelyheld medical device company from  until its acquisition by us in december  mr neels currently serves on the boards of directors of  biomedical inc arsenal medical inc bioventus llc and white pine medical inc all privatelyheld medical device companies and entellus medical inc and axotem inc each a publiclyheld medical device company mr neels also serves on the board of directors of christel house international and armici lovaniengis each a nonprofit organization mr neels was initially appointed to our board of directors pursuant to a board designation right granted to essex woodlands health ventures fund vii lp or essex woodlands fund vii an affiliate of essex woodlands under a securities purchase agreement dated as of october   as amended december   between us and essex woodlands fund vii as reflected in the biographical information summarized above mr neels has extensive business managerial executive and leadership experience in the medical device industry having served in various senior management positions including as chief operating officer of a publiclytraded medical device company in addition mr neels serves or has served on the boards of directors of several publiclytraded and privatelyheld medical device companies including serving on the board of directors of nellix which we acquired in december  source endologix inc on    sign up for equilar atlas and view guido j neelss full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like guido j neels more specifically youll be able to identify corporate executives in guido j neelss network and community follow changes in guido j neelss employment and moneyinmotion connect with guido j neels through your network of conections view full profile   search for over  executive profiles bio example guido j neels guido j neelss connections  sign up now to view guido j neelss  connections » michael grobstein board member bristolmyers squibb kristina m johnson board member the aes corporation john p engels vice president axogen inc daniel p harrington board member churchill downs incorporated mark s gold board member axogen inc keith e brauer board member endocyte inc nancyann m deparle board member cvs health corporation gregory g freitag dir general counsel and senior vice president business development axogen inc joseph a dejohn former general manager asiapacific and latin america endologix inc joseph p pellegrino chief financial officer treasurer secretary and director lemaitre vascular inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla jan koum board member facebook inc philip l milstein board member the marcus corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   caprally find investors features pricing about login sign up results filter all sectors energy healthcare technology other all stages seed early growth argentina australia brazil canada china france germany hong kong india ireland israel japan jersey korea luxembourg russia singapore sweden switzerland the netherlands united kingdom united states go guido j neels managing director  essex woodlands health ventures palo alto ca   paloaltoewhvcom companies affiliations  arsenal medical clear vascular endgenitor technologies endologix entellus medical oraya therapeutics proteus biomedical rox medical about guido j neels guido neels has over  years of experience developing international healthcare businesses from may  until retiring in november  mr neels served as chief operating officer of guidant corporation a world leader in the development of cardiovascular medical products where he was responsible for the global operations of guidant’s four operating units  cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions from december  to may  he was group chairman office of the president at guidant responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations from january  to december  he was president of guidant for europe middle east africa and canadannhe previously served as vice president of global marketing for vascular intervention and as managing director for german and central european operations from  to  until guidant was spun off as an independent public company from eli lilly and co mr neels held general management sales and marketing positions at lilly in the us and europe from  to  he held positions in information technology finance and manufacturing at raychem corporation in belgium and the usnnmr neels joined essex woodlands as a partner in august  and was promoted to managing director in  in addition to the portfolio company boards on which he serves mr neels also serves on the board of directors for arsenal medical and endgenitor technologies related professionals  terry gould partner  head of direct investments richard simoni partner brian k halak partner kim p kamdar partner immanuel thangaraj managing director cynthia doerr partner phyllis gardner partner gilbert gonzales partner mike gertner adjunct partner chris shen principal guy fish vice president alan levy venture partner dennis dougherty managing general partner james rosen partner chris grant senior vice president and managing director dave schulte managing director cristy barnes managing director jason lettmann principal carmichael roberts partner steven d weinstein managing director terry mcguire general partner tony natale   brendan oleary   kevin wasserstein managing director william link managing director mark brooks managing director josh baltzell managing director david milne managing partner john onopchenko cofounder  managing partner mudit jain partner reza zadno venture partner ryan harris partner show more features pricing about terms privacy help feedback contact us   caprally inc all rights reserved elgx guido j neels insider trades for endologix inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close endologix inc nasdaq elgx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus endologix inc after hours  quotes are delayed by  min jul    pm elgx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual guido j neels mr guido j neels is operating partner at essex woodlands health ventures inc chairman at white pine medical inc and industry expert at pearl street venture funds he is on the board of directors at bioventus inc axogen inc bioventus llc endologix inc entellus medical inc radiant medical inc  biomedical inc arsenal medical inc christel house international inc clear vascular inc oraya therapeutics inc and rox medical inc mr neels was previously employed as chairman by nellix inc vice presidentglobal marketing by vascular intervention chief operating officer by guidant corp a principal by eli lilly  co and a principal by raychem corp he also served on the board at lemaitre vascular inc biopure corp endgenitor technologies inc and essex woodlands health ventures fund vii lp mr neels received his undergraduate degree from université catholique de louvain and an mba from stanford graduate school of business transactions date shares transaction value     award at  per share      acquisition at  per share      acquisition at  per share      award at  per share      acquisition at  per share      award at  per share      acquisition at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr daniel t lemaitre chairman mr john d mcdermott chief executive officer  director mr robert d mitchell president mr vaseem mahboob chief financial officer  secretary mr w patrick stephens vice presidentresearch  development dr matthew thompson chief medical officer dr michael v chobotov chief technology officer ms meredith huetter vice presidentglobal medical affairs mr joseph a dejohn general managerasia pacific  latin america mr jeff stelk vice presidentunited states sales ms amanda l depalma vice presidentglobal marketing mr david m jennings vice presidenthuman resources ms shari l oquinn vice presidentregulatory  clinical affairs mr christopher g chavez independent director ms leslie v norwalk independent director mr thomas f zenty independent director mr gregory d waller independent director mr guido j neels independent director mr thomas c wilder independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest awhy one analyst calls this the ‘chart of the week month and potentially year’ athe cracked benchmark why some investors want a new standard for bonds a moneymaking lessons from the richest man who ever lived age’s stock falls as jeff immelt’s th and last quarter is another disappointment anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix aalphabet earnings a  billion hit for google potential youtube results for investors amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat atrump says he has ‘complete power to pardon’ achipotle earnings media coverage of the latest illness scare will put earnings targets at risk aexxon earnings will stock trade higher on expected secondquarter beat apay tv expected to lose more than a million subscribers in latest quarter aqualcomm’s issues go beyond apple fight ayogaworks ipo pulled on valuation concerns not market conditions aamazon’s foray into groceries means more mergers of food companies experts say athis is what should really worry you about stocks aeuro rally has room to run if this pattern continues to hold true aweekend roundup companies that may cut dividends  faang stocks and market bubbles  enjoy london on the cheap aattention shoppers ‘amazon effect’ is creating bargain stocks awhy you might want to avoid these  dividend stocks astocks brace for volatility in earnings deluge fed meeting looms loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  guido j neels executive profile  biography  bloomberg july    am et capital markets company overview of ew healthcare partners snapshotpeople  overviewboard memberscommittees executive profile guido j neels managing partner and operating partner ew healthcare partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr guido j neels is a managing partner and operating partner of essex woodlands health ventures since february  he was managing director since  mr neels joined essex woodlands health ventures as a partner in august  he serves as an interim chief executive officer at bioventus he is an industry expert at pearl street venture funds he has been with essex woodlands health venturesessex woodlands since  prior to joining essex woodlands he served  in a variety of management positions at guidant where he was responsible for the global operations of guidants four operating units  cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions mr neels served as the chief operating officer of guidant corporation from july  to november   where he was responsible for the global operations of guidants four operating units  cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions he served as a special advisor to the chairman of guidant llc from november  to december   he was responsible for the global operations of guidants four operating units cardiac rhythm management vascular intervention cardiac surgery and endovascular solutions he served as group chairman office of the president at guidant corporation from december  to july  responsible for worldwide sales operations corporate communications corporate marketing investor relations and government relations and its president of europe middle east africa and canada from january  to december  he served as the vice president of global marketing at vascular intervention from  to december  he served as managing director of guidant germany and central europe operations from  to  from  to  mr neels held various general management and sales and marketing positions at lilly in europe and the united states he was appointed as the general manager of united kingdom scandinavia and dealer countries he held positions in information technology finance and manufacturing at raychem corporation in belgium and the united states from  to  he serves as the chairman of white pine medical inc and nellix inc he serves as the chairman of oraya therapeutics inc he serves as a director of  biomedical inc clear vascular proteus biomedical wmr biomedical arsenal medical inc and rox medical he has been a director of novo as  entellus medical inc since november  and axogen inc since august   he serves as a member of board of managers at bioventus llc he has been a director of christel house international endgenitor technologies inc since september  and endologix inc since december   he served on the board of nellix inc from  to december  he served as an independent director of biopure corporation from august   to  radiant medical inc since april  and lemaitre vascular inc from  to august   he has  years of experience developing international healthcare businesses mr neels holds a business engineering degree from the university of leuven in belgium and a master of business administration degree from stanford university graduate school of businessread full background corporate headquarters  bryant streetpalo alto california united statesphone fax  board members memberships chairmannellix incdirectororaya therapeutics incdirectorarsenal medical incexecutive director and chairman of the board of directorswhite pine medical incdirector biomedical incmember of board of managersbioventus llcpresentdirectorendgenitor technologies incpresentdirectorentellus medical incpresentdirectorendologix incpresentdirectoraxogen inc education unknownother education katholieke universiteit leuvenmba stanford graduate school of business other affiliations guidant llcbiopure corporationradiant medical incendologix inclemaitre vascular inckatholieke universiteit leuvenstanford graduate school of businessaxogen incendgenitor technologies incpearl street venture fundsnellix incoraya therapeutics incentellus medical incarsenal medical incwhite pine medical inc biomedical incbioventus incessex woodlands fund ix lpbioventus llc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ew healthcare partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close